|
[1] American Association for the Study of Liver Diseases,European Association for the Study of the Liver. Hepatic encephalopathy in chronic liver disease:2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases[J]. J Hepatol,2014,61(3):642-659.
|
|
[2] TANG SH,CHEN H,HAN GH. Association between gut microbiota and hepatic encephalopathy in patients with liver cirrhosis[J]. J Clin Hepatol,2019,35(5):1109-1113.(in Chinese)汤世豪，陈辉，韩国宏．肠道菌群与肝硬化肝性脑病的关系[J]．临床肝胆病杂志，2019,35(5):1109-1113.
|
|
[3] LU BJ,ZHAO YH,AN YT,et al. Research advances in gut microbiota in liver cirrhosis and related complications[J]. J Clin Hepatol,2018,34(11):2433-2437.(in Chinese)鲁冰洁，赵亚红，安泳潼，等．肠道微生物在肝硬化及相关并发症中的研究进展[J]．临床肝胆病杂志，2018,34(11):2433-2437.
|
|
[4] SENGHOR B,SOKHNA C,RUIMY R,et al. Gut microbiota diversity according to dietary habits and geographical provenance[J]. Hum Microbiome J,2018,7-8:1-9.
|
|
[5] DAVID L,MAURICE CF,CARMODY RN,et al. Diet rapidly and reproducibly alters the human gut microbiome[J]. Nature,2014,505(7484):559-563.
|
|
[6] GRAF D,di CAGNO R,FK F,et al. Contribution of diet to the composition of the human gut microbiota[J]. Microb Ecol Health Dis,2015,26:26164.
|
|
[7] MOGHADAMRAD S,MCCOY KD,GEUKING MB,et al. Attenuated portal hypertension in germ-free mice:Function of bacterial flora on the development of mesenteric lymphatic and blood vessels[J]. Hepatology,2015,61(5):1685-1695.
|
|
[8] TABIBIAN J,O'HARA SP,TRUSSONI CE,et al. Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis[J]. Hepatology,2016,63(1):185-196.
|
|
[9] CHU H,DUAN Y,YANG L,et al. Small metabolites,possible big changes:A microbiota-centered view of non-alcoholic fatty liver disease[J]. Gut,2019,68(2):359-370.
|
|
[10] HE X,JI G,JIA W,et al. Gut microbiota and nonalcoholic fatty liver disease:Insights on mechanism and application of metabolomics[J]. Int J Mol Sci,2016,17(3):300.
|
|
[11] LYU XY,LI L. Clinical effect of rifaximin in treatment of complications associated with liver cirrhosis[J]. J Clin Hepatol,2018,34(7):1551-1554.(in Chinese)吕新月，李磊．利福昔明在肝硬化相关并发症中的应用[J]．临床肝胆病杂志，2018,34(7):1551-1554
|
|
[12] ZHU X,HAN Y,DU J,et al. Microbiota-gut-brain axis and the central nervous system[J]. Oncotarget,2017,8(32),53829-53838.
|
|
[13] SHARON G,SAMPSON TR,GESCHWIND DH,et al. The central nervous system and the gut microbiome[J]. Cell,2016,167(4):915-932.
|
|
[14] ARONIADIS OC,DROSSMAN DA,SIMRÉN M. Perspective on brain-gut communication:The American Gastroenterology Association and American Psychosomatic Society joint symposium on brain-gut interactions and the intestinal microenvironment[J]. Psychosom Med,2017,79(8):847-856.
|
|
[15] LYTE JM,PROCTOR A,PHILLIPS GJ,et al. Altered schaedler flora mice:An old defined microbiota animal model to study the new science of microbiota-gut-brain axis[J]. Behav Brain Res,2019,356:221-226.
|
|
[16] AHLUWALIA V,BETRAPALLY NS,HYLEMON PB,et al. Impaired gut-liver-brain axis in patients with cirrhosis[J]. Sci Rep,2016,6:26800
|
|
[17] QIN N,YANG F,LI A,et al. Alterations of the human gut microbiome in liver cirrhosis[J]. Nature,2014,513(7516):59-64.
|
|
[18] FUKUI H. Gut Microbiome-based Therapeutics in liver cirrhosis:basic consideration for the next step[J]. J Clin Transl Hepatol,2017,5(3):249-260.
|
|
[19] LACHAR J,BAJAJ JS. Changes in the microbiome in cirrhosis and relationship to complications:Hepatic encephalopathy,spontaneous bacterial peritonitis,and sepsis[J]. Semin Liver Dis,2016,36(4):327-330.
|
|
[20] WEISS N,BARBIER SAINT HILAIRE P,COLSCH B,et al. Cerebrospinal fluid metabolomics highlights dysregulation of energy metabolism in overt hepatic encephalopathy[J]. J Hepatol,2016,65(6):1120-1130.
|
|
[21] BENYOUB K,MULLER M,BONNET A,et al. Amounts of bile acids and bilirubin removed during single-pass albumin dialysis in patients with liver failure[J]. Ther Apher Dial,2011,15(5):504-506.
|
|
[22] TANAKA N,MATSUBARA T,KRAUSZ KW,et al. Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis[J]. Hepatology,2012,56(1):118-129.
|
|
[23] COLPITTS SL,KASPER LH. Influence of the gut microbiome on autoimmunity in the central nervous system[J]. J Immunol,2017,198(2):596-604.
|
|
[24] ARAB JP,MARTIN-MATEOS RM,SHAH VH,et al. Gut–liver axis,cirrhosis and portal hypertension:The chicken and the egg[J]. Hepatol Int,2018,12(Suppl 1):24-33.
|
|
[25] DAPITO DH,MENCIN A,GWAK GY,et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4[J]. Cancer Cell,2012,21(4):504-516.
|
|
[26] BAJAJ JS,BETRAPALLY NS,GILLEVET PM. Decompensated cirrhosis and microbiome interpretation[J]. Nature,2015,525(7569):e1-e2.
|
|
[27] DANTZER R. Neuroimmune interactions:From the brain to the immune system and vice versa[J] Physiol R,2018,98(1):477-504.
|
|
[28] ERHARDT S,SCHWIELER L,IMBEAULT S,et al. The kynurenine pathway in schizophrenia and bipolar disorder[J]. Neuropharmacology,2017,112(Pt B):297-306.
|
|
[29] LUO X,LUO S,ZHENG YY. Intestinal dysbacteriosis promotes intestinal intraepithelial T lymphocyte activation and proinflammatory cytokine secretion in mice[J]. Chin J Cell Mol Immunol,2016,32(8):1031-1035.(in Chinese)罗霞，罗爽，郑彦懿．肠道菌群失调增加肠上皮T淋巴细胞活化和促炎细胞因子分泌[J]．细胞与分子免疫学杂志，2016,32(8):1031-1035.
|
|
[30] QUAN M,XING HC. Research progress on intestinal flora and chronic liver disease[J/CD]. Chin J Liver Dis(Electronic Edition),2019,11(3):26-30.(in Chinese)全敏，邢卉春．肠道菌群与慢性肝病相关研究进展[J/CD]．中国肝脏病杂志(电子版)，2019,11(3):26-30.
|
|
[31] HOFFMANN D,PALUMBO F,RAVEL J,et al. Improving regulation of microbiota transplants[J]. Science,2017,358(6369):1390-1391.
|
|
[32] SARIN SK,PANDE A,SCHNABL B. Microbiome as therapeutic target in alcohol-related liver disease[J]. J Hepatol,2019,70(2):260-272.
|
|
[33] BAJA JS,KASSAM Z,FAGAN A,et al. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy:A randomized clinical trial[J]. Hepatology,2017,66(6):1727-1738.
|
|
[34] PHILIPS CA,PANDE A,SHASTTHRY SM,et al. Healthy donor fecal microbiota transplantation in steroidineligible severe alcoholic hepatitis:A pilot study[J]. Clin Gastroenterol Hepatol,2017,15(4):600-602.
|
DownLoad: